EDGAR Filing Documents for 0001062993-17-001283

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001062993-17-001283

Filing Date

2017-03-10

Accepted

2017-03-10 07:48:07

Documents

Period of Report

2017-03-10

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	form6k.htm	6-K	5188
2	EXHIBIT 99.1	exhibit99-1.htm	EX-99.1	19652
3	EXHIBIT 99.2	exhibit99-2.htm	EX-99.2	7698
4	EXHIBIT 99.3	exhibit99-3.htm	EX-99.3	7686
5	EXHIBIT 99.4	exhibit99-4.htm	EX-99.4	295471
6	GRAPHIC	exhibit99-1x1x1.jpg	GRAPHIC	4582
7	GRAPHIC	exhibit99-5x5x1.jpg	GRAPHIC	27189
8	GRAPHIC	exhibit99-5x6x1.jpg	GRAPHIC	33185
	Complete submission text file	0001062993-17-001283.txt		426575

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9

Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627

Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)